Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.61 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.59 |
| ▸ | TSHR | P16473 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | GLA | P06280 | 1/20 | 0.47 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | USP2 | O75604 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL2672089 | 0.98 | KDM4E (0.59) | KDM4EHSD17B10ALOX15TSHRSMN1; SMN2 | |
| SCHEMBL12226465 | 0.94 | KDM4E (0.55) | KDM4EHSD17B10ALOX15TSHRSMN1; SMN2 | |
| SCHEMBL28432244 | 0.92 | KDM4E (0.53) | KDM4EHSD17B10ALOX15TSHRSMN1; SMN2 | |
| SCHEMBL12226483 | 0.92 | KDM4E (0.53) | KDM4EHSD17B10ALOX15TSHRSMN1; SMN2 | |
| SCHEMBL17996821 | 0.90 | KDM4E (0.81) | KDM4EHSD17B10ALOX15TSHRSMN1; SMN2 | |
| SCHEMBL27315572 | 0.90 | HSD17B10 (0.74) | KDM4EHSD17B10ALOX15TSHRSMN1; SMN2 | |
| SCHEMBL18951860 | 0.90 | HSD17B10 (0.57) | KDM4EHSD17B10ALOX15TSHRSMN1; SMN2 | |
| SCHEMBL27330714 | 0.90 | HSD17B10 (0.74) | KDM4EHSD17B10ALOX15TSHRSMN1; SMN2 | |
| SCHEMBL12226466 | 0.84 | HSD17B10 (0.69) | KDM4EHSD17B10ALOX15TSHRSMN1; SMN2 | |
| Acetic Acid SCHEMBL7320116 | 0.82 | HSD17B10 (0.83) | KDM4EHSD17B10ALOX15TSHRSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 314 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2015020967-A1 | NBPT SOLUTIONS FOR PREPARING UREASE INHIBITED UREA FERTILIZERS PREPARED FROM N-SUBSTITUTED MORPHOLINES | WEYERHAEUSER NR COMPANY (US) | 2015-02-12 | — | — | WO | claimed |
| CN-1232560-C | Polymer containing hetero atom, photosensitive resin composition containing the polymer and application | IND TECH RES INST (CN) | 2005-12-21 | — | — | CN | claimed |
| CN-1465606-A | Polymer containing hetero atom, photosensitive resin composition containing the polymer and application | 财团法人工业技术研究院 | 2004-01-07 | — | — | CN | claimed |
| CN-1114629-C | Unsaturated bond branched copolymer and photoresist composition thereof | JURIDICAL PERSON IND TECH INST (CN) | 2003-07-16 | — | — | CN | claimed |
| CN-1303876-A | Unsaturated bond branched copolymer and photoresist composition thereof | ACADEMY OF IND TECHNOLOGY (CN) | 2001-07-18 | — | — | CN | claimed |
| EP-4558546-A1 | PHOTOCURABLE HYDROGEL COMPOSITIONS | Tympanogen, Inc. (US) | 2025-05-28 | — | — | EP | disclosed |
| EP-3885340-B1 | ANDROGEN RECEPTOR MODULATING COMPOUNDS | ORION CORP (FI) | 2024-11-27 | — | — | EP | disclosed |
| EP-4449533-A1 | A BATTERY COMPRISING A HIGH-CONCENTRATED ELECTROLYTE AND A NEGATIVE ELECTRODE HAVING A METAL SUBSTRATE AND A PROTECTIVE LAYER | Umicore (BE) | 2024-10-23 | — | — | EP | disclosed |
| EP-4449521-A1 | A NEGATIVE ELECTRODE COMPRISING A METAL SUBSTRATE AND A PROTECTIVE LAYER | Umicore (BE) | 2024-10-23 | — | — | EP | disclosed |
| CN-114867761-B | Acrylic polymer, curable composition, and cured product thereof | 三菱化学株式会社 | 2024-02-09 | — | — | CN | disclosed |
| WO-2024020475-A1 | PHOTOCURABLE HYDROGEL COMPOSITIONS | TYMPANOGEN, INC. (US) | 2024-01-25 | — | — | WO | disclosed |
| WO-2023250513-A1 | 13-MEMBERED MACROLIDE COMPOUNDS FOR TREATING DISEASES MEDIATED BY ABNORMAL PROTEIN TRANSLATION | ZIKANI THERAPEUTICS, INC. (US) | 2023-12-28 | — | — | WO | disclosed |
| EP-1025088-A1 | IMIDAZOLE DERIVATIVES AND THEIR USE AS FARNESYL PROTEIN TRANSFERASE INHIBITORS | AstraZeneca UK Limited (GB) | 2000-08-09 | — | — | EP | disclosed |
| WO-1999020611-A1 | IMIDAZOLE DERIVATIVES AND THEIR USE AS FARNESYL PROTEIN TRANSFERASE INHIBITORS | ZENECA LIMITED (GB) | 1999-04-29 | — | — | WO | disclosed |
| CN-1107146-A | A process for preparing a composition containing benzoheterocycles | OTSUKA PHARMA CO LTD (JP) | 1995-08-23 | — | — | CN | disclosed |
| CN-1027505-C | Process for preparing benzoheterocyclic compounds | OTSUKA PHARMA CO LTD (JP) | 1995-01-25 | — | — | CN | disclosed |
| CN-1091288-A | The oxytocin antagonist | OTSUKA PHARMA CO LTD (JP) | 1994-08-31 | — | — | CN | disclosed |
| CN-1066653-A | BENZOHETEROCYCLIC COMPOUNDS | OTSUKA PHARMA CO LTD (JP) | 1992-12-02 | — | — | CN | disclosed |
| CN-1051038-A | BENZOHETEROCYCLIC COMPOUNDS | OTSUKA PHARMA CO LTD (JP) | 1991-05-01 | — | — | CN | disclosed |
| US-4209517-A | α-Ethylenic alcohols and ketones, their preparation, and their use as medicaments | UNICLER (FR) | 1980-06-24 | — | — | US | disclosed |